HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

thromboxane A3

Also Known As:

TXA3

Networked: 4 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Lipids: 114793
- Fatty Acids: 27405
  - Unsaturated Fatty Acids: 8236
    - Eicosanoids: 3262
      - Arachidonic Acids: 122
        Thromboxanes: 2439
        thromboxane A3: 4
    - Essential Fatty Acids: 734
      - Arachidonic Acids: 122
        Thromboxanes: 2439
        thromboxane A3: 4

Experts

1.	Amin, Mohammad Tohidul: 1 article (01/2022)
2.	Baral, Prodip Kumar: 1 article (01/2022)
3.	Hossain, Mohammad Salim: 1 article (01/2022)
4.	Rashid, Md Mamun Or: 1 article (01/2022)
5.	Acín, Maria T: 1 article (11/2010)
6.	Bastida, S: 1 article (11/2010)
7.	Higueras, F J: 1 article (11/2010)
8.	Sánchez-Muniz, F J: 1 article (11/2010)
9.	Vaquero, Maria P: 1 article (11/2010)
10.	Villalobos, Maria E: 1 article (11/2010)

Related Diseases

1.	Thrombosis (Thrombus) 05/01/1981 - "No appreciable formation of TxA3 and PGI3 is observed, although arterial thrombosis is depressed and bleeding time is prolonged. " 01/01/1979 - "The prostacyclin:thromboxane A2 ratio is important in the control of thrombus formation; manipulation of this ratio by small doses of aspirin (which will inhibit mainly platelet cyclooxygenase), a selective inhibitor of thromboxane formation, or the dietary use of a fatty acid like eicosapentaenoic acid (which would be the precursor for a delta17-prostacyclin (PGI3) but is transformed by the platelets into nonaggregating thromboxane A3) might have beneficial effects as antithrombotic therapies. "
2.	Inflammation (Inflammations) 11/01/2010 - "In addition, as a precursor of EPA and this last fatty acid of thromboxane A3, prostacyclin I3, serie-3 prostaglandines and serie 5-leukotrines and inhibitor/modulator of thromboxane A2, prostacyclin I2, serie-2 prostaglandines and serie 4-leukotrienes formation, the α-linolenic acid may reduce inflammation and thrombogenesis. "
3.	Heart Diseases (Heart Disease) 01/01/2022 - "Prostaglandins of 3 series, leukotrienes of 5 series, and thromboxane A3 from eicosapentaenoic acid exhibit anti-inflammatory, vasodilatory, and platelet anti-aggregatory effects that may also contribute to the control of pre-existing pulmonary and cardiac diseases. "

Related Drugs and Biologics

1.	Eicosapentaenoic Acid
2.	Thromboxane A2 (A2, Thromboxane)
3.	Epoprostenol (Prostacyclin)
4.	Fatty Acids (Saturated Fatty Acids)
5.	prostaglandin I3
6.	alpha-Linolenic Acid (Linolenic Acid)
7.	Leukotrienes
8.	Thromboxanes
9.	Prostaglandins
10.	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)

Related Therapies and Procedures

1.	Therapeutics